Clinical Trial Update: Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating two doses of solifenacin succinate in women with overactive bladder has completed and posted results (2014).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Detrusor Overactivity
• Overactive Bladder

Drugs mentioned

• Solifenacin succinate (solifenacin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Detrusor Overactivity, Overactive Bladder | Phase 4 | Status: COMPLETED | Results posted: 2014-04-07